Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
-18.7K
-
Total reported value, excl. options
-
$2.26B
-
Value change
-
-$2.2M
-
Put/Call ratio
-
0.47
-
Number of buys
-
1
-
Number of sells
-
-5
-
Price
-
$123.61
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2013
202 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2013.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.81M shares), ARIEL INVESTMENTS, LLC (1.1M shares), VANGUARD GROUP INC (1.09M shares), ROYCE & ASSOCIATES LLC (1.07M shares), LEVIN CAPITAL STRATEGIES, L.P. (803K shares), Champlain Investment Partners, LLC (782K shares), BlackRock Institutional Trust Company, N.A. (710K shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (634K shares), BlackRock Fund Advisors (583K shares), and State Street Corp (550K shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.